PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study reveals structure of protein and permits search for drugs against neglected diseases

Discovery by Brazilian scientists paves the way for the study of more potent molecules capable of directly destroying parasites underlying elephantiasis and cutaneous leishmaniasis, with fewer adverse side-effects

Study reveals structure of protein and permits search for drugs against neglected diseases
2021-01-07
(Press-News.org) Brazilian researchers have managed to decipher the structure of a protein found in parasites that cause neglected tropical diseases, paving the way to the development of novel medications. Thanks to the discovery it will be possible to seek more potent molecules capable of destroying the pathogens directly, with fewer adverse side-effects for patients.

The study detailed the structural characteristics of the protein deoxyhypusine synthase (DHS), found in Brugia malayi, one of the mosquito-borne parasites that cause elephantiasis, and in Leishmania major, the protozoan that causes cutaneous leishmaniasis.

Elephantiasis, also known as lymphatic filariasis, is an infection of the lymph system that can lead to swelling of the legs, arms, and genitalia. It may also harden and thicken the skin, limiting movement, and hindering normal activities.

Cutaneous leishmaniasis produces skin lesions weeks or months after the insect bite that transfers the parasite. Lesions may persist for years and leave scars similar to those caused by burns. Over 300,000 cases were notified in Brazil between 2003 and 2018, according to data from the Ministry of Health.

The study is reported in an article published in PLOS Neglected Tropical Diseases. The first authors are Suélen Silva and Angélica Klippel, PhD candidates at São Paulo State University (UNESP) in Araraquara. Silva is in the Biotechnology  Program, and Klippel is in Bioscience and Biotech Applied to Pharmacy, with a scholarship from FAPESP, supervised by Cleslei Zanelli. 

The research is conducted under the aegis of the National Institute of Science and Technology (INCT) for Open-Access Medicinal Chemistry hosted by the University of Campinas's Center for Medicinal Chemistry (CQMED-UNICAMP). It receives funding from FAPESP, and federally from the National Council for Scientific and Technological Development (CNPq) at the Ministry of Science and Technology and CAPES, the Ministry of Education's Coordination for the Improvement of Higher Education Personel.

The group achieved two important major advances with regard to DHS: standardization of a yeast-based platform to study the enzyme for Leishmania major, and three-dimensional assembly of the molecule found in the elephantiasis protozoan.

The identification of this novel target will now be followed by more research to develop or find molecules that inhibit DHS-mediated biochemical processes and stop the disease from progressing. If specific inhibitors are identified as the basis for drug development, it will be possible to reduce or completely avoid the adverse side-effects of current treatments, such as fever, nausea, and insomnia. In the case of elephantiasis, some medications are not even capable of killing adult worms.

"At CQMED we try to elucidate proteins that haven't been studied in depth and to determine their crystal structure. The study revealed the structure of DHS in these parasites for the first time. We began with these two parasites [Brugia and Leishmania], but we want to go on to investigate four more organisms including Plasmodium, which causes malaria," Katlin Massirer, principal investigator of the INCT, told Agência FAPESP. Massirer is affiliated with the University of Campinas's Center for Molecular Biology and Genetic Engineering (CBMEG-UNICAMP). 

Crystallography is an essential tool in research on the three-dimensional structure of proteins. Scientists use the technique to analyze the positions of the proteins' atoms and their interactions, to understand how they act in the human organism, and to investigate how a prospective drug will have to bind to a given protein. Analyzing crystal structure also helps understand how each drug works so as to enhance its efficacy.

The study included in vitro synthesis of the active enzyme, the form in which DHS acts on the parasite, and assays to test its activity while screening the molecules that could become novel medications. 

"The structure of the protein serves as a basis on which to identify the differences and try to find an inhibitor that will fit into the parasite's enzyme without affecting the similar protein found in humans. It's a big challenge," Klippel said.

Progress

According to Massirer, it takes between 12 and 15 years on average to research, develop and bring novel medications to market, but in the case of neglected tropical diseases (NTDs) lead times can be even longer because so little research is done on these health problems. "You could say that the stage we're at is equivalent to two years of this process," she said.

NTDs are estimated to affect some 1.5 billion people in more than 150 countries, mainly in the world's poorest regions. Besides leishmaniasis and elephantiasis, the list of NTDs published by the World Health Organization (WHO) includes Chagas disease, schistosomiasis, dengue fever, and chikungunya.

More than 350 research institutions, civil society organizations, companies, and governments of countries around the world signed up to celebrate the first-ever World NTD Day on January 30, 2020. The date was chosen because it was the anniversary of the 2012 London Declaration on NTDs, which redoubled global efforts to eradicate NTDs. Pharmaceutical companies, donors, endemic countries, and NGOs committed to control, eliminate or eradicate ten diseases by 2020 and improve the lives of over a billion people. Not all the goals have been met, however.

Scant interest in NTDs was one of the reasons Klippel chose to work on the problem. "For my PhD research I wanted to leverage my training as a pharmacist and to focus on a neglected area, to participate in something important but not highly valued," she said. "Every stage is a victory. We've built a tool, and now we must take the next step."

At CQMED, Massirer explained, the next step will consist of acquiring DHS from other species and at the same time searching repositories for molecules at home and abroad. The research has been proceeding more slowly because of the COVID-19 pandemic. "Our center lets groups from anywhere in Brazil propose innovative projects for collaborative research by the network," she said.

The institute's mission includes fostering partnerships among researchers at different centers to investigate little-studied proteins and increase the impact of discoveries.

CQMED is a unit of the Brazilian Agency for Industrial Research and Innovation (EMBRAPII). It was created with support from FAPESP through its Research Partnership for Technological Innovation Program (PITE), in cooperation with the Structural Genomics Consortium (SGC), a collaborative network of academics, pharmaceutical companies, and funding agencies working together to accelerate drug development. 

INFORMATION:

About São Paulo Research Foundation (FAPESP)

The São Paulo Research Foundation (FAPESP) is a public institution with the mission of supporting scientific research in all fields of knowledge by awarding scholarships, fellowships and grants to investigators linked with higher education and research institutions in the State of São Paulo, Brazil. FAPESP is aware that the very best research can only be done by working with the best researchers internationally. Therefore, it has established partnerships with funding agencies, higher education, private companies, and research organizations in other countries known for the quality of their research and has been encouraging scientists funded by its grants to further develop their international collaboration. You can learn more about FAPESP at http://www.fapesp.br/en and visit FAPESP news agency at http://www.agencia.fapesp.br/en to keep updated with the latest scientific breakthroughs FAPESP helps achieve through its many programs, awards and research centers. You may also subscribe to FAPESP news agency at http://agencia.fapesp.br/subscribe.


[Attachments] See images for this press release:
Study reveals structure of protein and permits search for drugs against neglected diseases

ELSE PRESS RELEASES FROM THIS DATE:

Proteogenomics offers insight to treating head and neck squamous cell carcinoma

2021-01-07
HOUSTON - (Jan. 7, 2021) - Proteogenomic analysis may offer new insight into matching cancer patients with an effective therapy for their particular cancer. A new study identifies three molecular subtypes in head and neck squamous cell carcinoma (HNSCC) that could be used to better determine appropriate treatment. The research led by Baylor College of Medicine, Johns Hopkins University and the National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium (CPTAC) is published in the journal Cancer Cell. Researchers profiled proteins, phosphosites and signaling ...

For the right employees, even standard information technology can spur creativity

2021-01-07
TROY, N.Y. -- In a money-saving revelation for organizations inclined to invest in specialized information technology to support the process of idea generation, new research suggests that even non-specialized, everyday organizational IT can encourage employees' creativity. Recently published in the journal Information and Organization, these findings from Dorit Nevo, an associate professor in the Lally School of Management at Rensselaer Polytechnic Institute, show standard IT can be used for innovation. Furthermore, this is much more likely to happen when the technology is in the hands of employees who are motivated to master technology, understand their role in the organization, ...

Mediterranean diet may decrease risk of prostate cancer progression

2021-01-07
In a study to examine a Mediterranean diet in relation to prostate cancer progression in men on active surveillance, researchers from The University of Texas MD Anderson Cancer Center found that men with localized prostate cancer who reported a baseline dietary pattern that more closely follows the key principles of a Mediterranean-style diet fared better over the course of their disease. "Men with prostate cancer are motivated to find a way to impact the advancement of their disease and improve their quality of life," said Justin Gregg, M.D., assistant professor of Urology and lead author of the study, published today in Cancer. ...

Beating the bulge with a nice cup of tea

2021-01-07
Tsukuba, Japan - Does losing weight while you sleep sound too good to be true? According to a study by the University of Tsukuba, it seems that drinking oolong tea might help you do just that. While all tea comes from the same plant, Camellia sinensis, the degree of oxidation, a chemical reaction that turns tea leaves black, defines its specific type. For example, green tea is unoxidized and mild in flavor, while the distinctive color of black tea comes from complete oxidation. Oolong tea, being only partially oxidized, lies somewhere in between and displays characteristics ...

A brain mechanism underlying 'vision' in the blind is revealed

A brain mechanism underlying vision in the blind is revealed
2021-01-07
Some people have lost their eyesight, but they continue to "see." This phenomenon, a kind of vivid visual hallucination, is named after the Swiss doctor, Charles Bonnet, who described in 1769 how his completely blind grandfather experienced vivid, detailed visions of people, animals and objects. Charles Bonnet syndrome, which appears in those who have lost their eyesight, was investigated in a study led by scientists at the Weizmann Institute of Science. The findings, published today in Brain, suggest a mechanism by which normal, spontaneous activity in the visual centers of the brain can trigger visual hallucinations in the blind. Prof. Rafi Malach and his group members of the Institute's Neurobiology Department research the phenomenon of spontaneous "resting-state" ...

Significant number of patients with sudden loss of consciousness need pre-hospital critical care

2021-01-07
Research from life-saving charity Air Ambulance Kent Surrey Sussex (KSS) in partnership with the University of Surrey has shown the benefits of dispatching HEMS to patients with a sudden, unexplained LOC of medical origin and a high prevalence of acute neurological pathology. The study - which is believed to be the first published about HEMS dispatch to non-trauma (neuro) cases - also highlights how HEMS dispatchers in dialogue with ambulance personnel are able to select patients requiring HEMS-specific interventions and, based on its findings, identifies opportunities to improve triage for these patients. Through a retrospective study of all patients with a LOC ...

Research shows rising lizard temperatures may change predator-prey relationship with snakes

Research shows rising lizard temperatures may change predator-prey relationship with snakes
2021-01-07
In a study spanning four decades, researchers from the University of Hong Kong's Research Division for Ecology & Biodiversity (HKU) in the Faculty of Science, and Toho University's Department of Biology (Toho), Japan, have discovered that predation by snakes is pushing lizards to be active at warmer body temperatures on islands where snakes are present, in comparison to islands free from snakes. Their work also detected significant climatic warming throughout the years and found lizard body temperatures to have also increased accordingly. The findings show that lizard thermal biology is highly dependent on predation pressures ...

Peeking inside 'mini-brains' could boost understanding of the human brain

2021-01-07
Geneva, Switzerland, 7 January 2021 - 'Mini-brains' are pin-head sized collections of several different types of human brain cell. They are used as a tool, allowing scientists to learn about how the brain develops, study disease and test new medicines. Personalized 'mini-brains' can be grown from stem cells generated from a sample of human hair or skin and could shed light on how brain disease progresses in an individual and how this person may respond to drugs. Research published today by a team of scientists and engineers from HEPIA and the Wyss Center for Bio and Neuroengineering, in the journal Frontiers in Bioengineering and Biotechnology, has revealed ...

Faulty metabolism of Parkinson's medication in the brain linked to severe side effects

2021-01-07
Until now, the reason why the drug levodopa (L-Dopa), which reduces the motor symptoms of Parkinson's disease, declines in efficacy after a few years' use has been unknown. A side effect that then often occur is involuntary movements. A Swedish-French collaboration, led from Uppsala University, has now been able to connect the problems with defective metabolism of L-Dopa in the brain. The study is published in Science Advances. "The findings may lead to new strategies for treating advanced Parkinson's," says Professor Per Andrén of the Department of Pharmaceutical Biosciences at Uppsala University. He and Dr Erwan Bézard of the University of Bordeaux, France, headed ...

Native biodiversity collapse in the Eastern Mediterranean

Native biodiversity collapse in the Eastern Mediterranean
2021-01-07
The coastline of Israel is one of the warmest areas in the Mediterranean Sea. Here, most marine species have been at the limits of their tolerance to high temperatures for a long time - and now they are already beyond those limits. Global warming has led to an increase in sea temperatures beyond those temperatures that Mediterranean species can sustain. Consequently, many of them are going locally extinct. Paolo Albano's team quantified this local extinction for marine molluscs, an invertebrate group encompassing snails, clams and mussels. They thoroughly surveyed the Israeli coastline and ...

LAST 30 PRESS RELEASES:

Being physically active, even just a couple of days a week, may be key to better health

High-fat diet promote breast cancer metastasis in animal models

A router for photons

Nurses and AI collaborate to save lives, reduce hospital stays

Multi-resistance in bacteria predicted by AI model

Tinker Tots: A citizen science project to explore ethical dilemmas in embryo selection

Sensing sickness

Cost to build multifamily housing in California more than twice as high as in Texas

Program takes aim at drinking, unsafe sex, and sexual assault on college campuses

Inability to pay for healthcare reaches record high in U.S.

Science ‘storytelling’ urgently needed amid climate and biodiversity crisis

KAIST Develops Retinal Therapy to Restore Lost Vision​

Adipocyte-hepatocyte signaling mechanism uncovered in endoplasmic reticulum stress response

Mammals were adapting from life in the trees to living on the ground before dinosaur-killing asteroid

Low LDL cholesterol levels linked to reduced risk of dementia

Thickening of the eye’s retina associated with greater risk and severity of postoperative delirium in older patients

Almost one in ten people surveyed report having been harmed by the NHS in the last three years

Enhancing light control with complex frequency excitations

New research finds novel drug target for acute myeloid leukemia, bringing hope for cancer patients

New insight into factors associated with a common disease among dogs and humans

Illuminating single atoms for sustainable propylene production

New study finds Rocky Mountain snow contamination

Study examines lactation in critically ill patients

UVA Engineering Dean Jennifer West earns AIMBE’s 2025 Pierre Galletti Award

Doubling down on metasurfaces

New Cedars-Sinai study shows how specialized diet can improve gut disorders

Making moves and hitting the breaks: Owl journeys surprise researchers in western Montana

PKU Scientists simulate the origin and evolution of the North Atlantic Oscillation

ICRAFT breakthrough: Unlocking A20’s dual role in cancer immunotherapy

How VR technology is changing the game for Alzheimer’s disease

[Press-News.org] Study reveals structure of protein and permits search for drugs against neglected diseases
Discovery by Brazilian scientists paves the way for the study of more potent molecules capable of directly destroying parasites underlying elephantiasis and cutaneous leishmaniasis, with fewer adverse side-effects